KENILWORTH, N.J., Oct. 21 /PRNewswire-FirstCall/ -- Schering-Plough Corporation will webcast its “R&D and Product Review” meeting for analysts and portfolio managers, which is being held on Nov. 1, 2005 from 9 a.m. (EST) to 1 p.m. Fred Hassan, Schering-Plough’s chairman and CEO, and other members of management will host the meeting. The meeting will review the company’s Action Agenda for transformational change, review current products and new compounds in development, and provide perspective on the company’s and the industry’s operating environment.
At 9 a.m. on that day, a live webcast (audio and slides) of the meeting will be available by going to the Schering-Plough corporate Web site, www.schering-plough.com, and clicking on the “Presentations/Webcasts” link. A replay of the webcast will be available starting at approximately 6 p.m. on Nov. 1, through 5 p.m. on Dec. 1.
Schering-Plough is a global science-based health care company with leading prescription, consumer and animal health products. Through internal research and collaborations with partners, Schering-Plough discovers, develops, manufactures and markets advanced drug therapies to meet important medical needs. Schering-Plough’s vision is to earn the trust of the physicians, patients and customers served by its more than 30,000 people around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com.
Schering-Plough
CONTACT: Denise K. Foy, +1-908-298-7616, or Investor Contact, Alex Kelly,+1-908-298-7436
Web site: http://www.schering-plough.com//
Company News On-Call: http://www.prnewswire.com/comp/777050.html/
